Abstract

PurposeEvaluation of survival of meniscal allograft transplantation (MAT) and postoperative patient-reported outcome (PRO), and their association with prior interventions of the knee.MethodsA prospective consecutive study of 109 consecutive patients who had an arthroscopic meniscal allograft transplantation (MAT) between 1999 and 2017 by a single surgeon. Patients were assessed with KOOS scores, preoperative and after a minimal follow-up of 2 years. Furthermore, two anchor questions (whether expectations were met and overall satisfaction, on a five-point Likert scale) were asked. Additionally, prior interventions to MAT were evaluated.ResultsPrior to MAT, patients had undergone an average of 2.8 (range 1–14) of surgical procedures of the knee. Overall, mean allograft survival was 16.1 years (95% CI 14.8–17.5 years). Higher age at surgery was associated with lower MAT survival: hazard ratio for MAT failure was 1.19 per year increase (95% CI 1.04 to 1.36, p = 0.009). At 4.5 years (IQR, 2–9) of follow-up, all KOOS score were still improved compared to baseline. Age below 35 years, simultaneous anterior cruciate ligament reconstruction and number of knee surgeries before MAT were associated with lower KOOS scores. Overall patient expectations and overall satisfaction after MAT were not associated with preoperative patient characteristics nor with the number or kind of preoperative interventions.ConclusionMeniscal allograft transplantation has a good overall survival with a clinically relevant improvement. Both meniscal allograft survival and PRO were associated with age. PRO was lower in patients younger than 35 years at time of MAT and meniscal allograft survival was worse in patients older than 50 years. PRO was associated with preoperative patient characteristics and number of surgical procedures prior to MAT. All patients reported improved postoperative satisfaction and met expectations after MAT, both independent of the preoperative history of knee interventions.Level of evidenceLevel III.Trial registration Medical ethical review board (METC) number: 17–104 (7 August 2017).Dutch Trial Register (NTR) number: NTR6630 (4 July 2017).

Highlights

  • Partial or total meniscectomy is often performed when damaged meniscal tissue cannot be repaired due to unfavorable conditions, type of meniscal tear, or when conservative treatment failed in the presence of a locking knee

  • Failure of the meniscal allograft transplantation (MAT) occurred in 11 patients (10%); 2 medial and 9 lateral meniscal allografts failed after a mean of 8.0 years

  • The most important findings of this study were that both meniscal allograft survival and patient-reported outcome were associated with age; patientreported outcome measures (PROMs) were lower in patients younger than 35 years and MAT failure rate was higher in patients older than 35 years

Read more

Summary

Introduction

Partial or total meniscectomy is often performed when damaged meniscal tissue cannot be repaired due to unfavorable conditions, type of meniscal tear, or when conservative treatment failed in the presence of a locking knee. Such a (partial) meniscectomy will alter the biomechanical and biological conditions in the knee joint [5]. 36,000 arthroscopies for meniscal pathology are performed annually [21] Some of these patients develop a postmeniscectomy syndrome [17]. The first meniscal allograft transplantation (MAT) in The Netherlands was performed in 1989 [27], and until 1999, it was performed by an open procedure. Short- and long-term outcomes of both open and arthroscopic MAT have shown positive results in terms of pain relief and functional improvement [3, 25]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call